Clinical trials: Immune Checkpoint Inhibitor-associated Myocarditis, open to volunteers

Immune Checkpoint Inhibitor-associated Myocarditis

ATROPOS: Survival Analysis of ICI-associated Myocarditis

• Recruiting
• Age: All ages
• Observational study

ATROPOS is an international, registry-based observational study of cancer patients with immune checkpoint inhibitor-associated myocarditis (ICI-M).

Trial name

ATROPOS (NCT07633587)

Where

France

Volunteers

1,500 people

Sponsor

Groupe Hospitalier Pitie-Salpetriere